Anastrocare 1 Mg Tablet

What is Anastrocare 1 mg tablet

Anastrocare 1 mg is a specialized endocrine therapy medication designed for the treatment of hormone-sensitive Breast Cancer in postmenopausal women. Its active component is Anastrozole (1mg). This third-generation non-steroidal aromatase inhibitor effectively blocks the conversion of Androgens to Estrogens throughout the body, particularly in peripheral tissues where most Estrogen is produced after menopause.

This medication plays a pivotal role in contemporary breast cancer management strategies, serving as both adjuvant therapies following surgery for early-stage disease and as first-line treatment for advanced metastatic Breast Cancer.

Clinical research has established its superiority over previous standards of care, with significant improvements in disease-free survival rates and reduced risk of Cancer recurrence in appropriate patient populations.

Medicare Remedies is the trusted manufacturer of Anastrocare 1 mg, bringing decades of pharmaceutical expertise to ensure consistent medication quality and therapeutic efficacy through their advanced formulation technologies and comprehensive quality assurance protocols.

What are the benefits of Anastrocare 1 mg tablet

Anastrocare 1 mg functions by specifically targeting and inhibiting the aromatase enzyme system. In postmenopausal women, this enzyme complex converts adrenal androgens into Estrogens in peripheral tissues, including breast tissue, fat, muscle, and Cancer.

Anastrocare creates a profound Estrogen deprivation environment by blocking this conversion, thereby eliminating the primary growth stimulus for Estrogen receptor-positive breast cancer cells.

Clinical studies have documented several significant therapeutic advantages:

• More reduction in breast cancer recurrence risk compared to Tamoxifen.
• Demonstrated efficacy in both early-stage and advanced metastatic settings.
• Reduced incidence of thromboembolic events and endometrial abnormalities.

It is crucial to note that Anastrocare requires consistent daily administration to maintain therapeutic efficacy, as Estrogen suppression effects diminish rapidly if doses are missed or treatment is discontinued prematurely.

How to take Anastrocare 1 mg tablet

Anastrocare 1 mg is a prescription medication that should be taken as per your doctor's instructions. Here are the general guidelines:

• Take 1 tablet (1 mg) once daily, ideally at the same time each day.
• Swallow whole with a full glass of water; do not crush or chew.
• It may be taken either with or without food according to personal preference.
• Do not exceed the prescribed dosage of this medication.

Strength and substitutes

Currently, there are no strength alternatives available for Anastrocare. However, the following substitutes are available:

View all substitutes

What are the side effects of Anastrocare 1 mg tablet

Anastrocare is generally well-tolerated relative to cytotoxic chemotherapy. However, it may cause side effects, including:

• Joint and muscle pain (arthralgia and myalgia)
• Hot flashes and night sweats
• Decreased bone mineral density over time
• Mild nausea or gastrointestinal discomfort
• Mood changes or mild depression

These adverse effects are typically manageable and often diminish intensity over the first few months of treatment. Side effects that significantly impact the quality of life should be promptly discussed with your healthcare provider, as interventions are available to mitigate most symptoms.

Safety Advice

Liver disease

Patients with mild-to-moderate hepatic impairment generally do not require dosage adjustment of Anastrocare, though liver function should be monitored periodically. Those with severe liver dysfunction should be treated with caution due to potential alterations in drug metabolism and clearance, which could increase drug exposure and related adverse effects.

Kidney impairment

No specific dose adjustments are required for patients with renal impairment as Anastrocare undergoes hepatic metabolism with minimal renal elimination. However, patients with severe kidney disease should be monitored more frequently for potential adverse effects, although clinical pharmacokinetic studies have shown minimal impact of renal dysfunction on drug handling.

Pregnant and breastfeeding women

Anastrocare is strictly contraindicated during pregnancy as it may cause fetal harm through its anti-estrogenic effects. While the medication is primarily indicated for postmenopausal women, younger patients with chemically or surgically induced menopause must use effective contraception during treatment. Breastfeeding is also contraindicated during Anastrocare therapy.

Avoid

Avoid supplements containing phytoestrogens such as soy isoflavones, red clover, and black cohosh, as these may theoretically interfere with the therapeutic action of Anastrocare. Excessive alcohol consumption should be limited, as it may compound the risk of osteoporosis. Vitamin E supplements at high doses may interact with Anastrozole and should be discussed with your healthcare provider.